Resumen
El manejo del paciente con estado migrañoso en urgencias incluye un arsenal terapéutico multimodal en búsqueda de la mejoría del dolor y la reducción de la recurrencia. La mayoría de los pacientes responde al manejo inicial, pero en casos no despreciables este resultado no se obtiene con las medicaciones de primera línea y es necesario el uso de otros medicamentos y opciones terapéuticas que incluyen: bloqueos pericraneales, lidocaína, levetiracetam, propofol y, en casos seleccionados, el uso de opiodes. En este escrito se presenta un caso clínico de migraña que no mejora con el manejo inicial en urgencias y requiere el uso de otras opciones.
Citas
Avcu N, Dogan NO, Pekdemir M, Yaka E, Yiknaz S, Alyesil C, et al. Intranasal lidocaine in acute treatment of migraine: a randomized controlled trial. Ann Emerg Med. 2017;69(6):743-51.
Swidan SZ, Lake AE III, Saper JR. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Headache Rep. 2005;9(1):65-70.
Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia. 2003;23(10):963-71.
Rosen N, Marmura M, Abbas M, Silberstein S. Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache. 2009;49(2): 286-91.
Gil-Gouveia R, Goadsby PJ. Neuropsychiatric side effects of lidocaine: examples from the treatment of headache and a review. Cephalalgia. 2006;26:1399.
Friedman B. Migraine in the Emergency Department. Neurol Clin. 2019;37:743-52.
Friedman BW, West J, Vinson DR, Minen M, Restivo A, Gallagher E. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey. Cephalalgia. 2015;35(4):301-9.
Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med. 2008;52(6):705-13.
Friedman BW, Irizarry E, Solorzano C, Latev A, Rosa K, Zias E. Randomized study of IV prochlorperazine plus diphen ramine vs IV hydromorphone for migraine. Neurology. 2017; 89(20):2075-82.
Friedman BW, Mohamed S, Robbins MS, Irizarry E, Tarsia V, Pearlman S, et al. A randomized, sham-controlled trial of bilateral greater occipital nerve blocks with bupivacaine for acute migraine patients refractory to standard emergency department treatment with metoclopramide. Headache. 2018;58(9):1427-34.
Allen SM, Mookadam F, Cha SS, Freeman JA, Staling AJ, Mookadam M. Greater occipital nerve block for acute treatment of migraine headache: A large retrospective cohort study. J Am Board Fam Med. 2018;31 (2):211-18.
Soleimanpour H, Taheraghdam A, Ghafouri RR, Taghizadiet A, Mariany K, Soleimannpour M. Improvement of refractory migraine headache by propofol: Case series. Int J EmergMed. 2012;5(1):19.
Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock R. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depress Anxiety. 2019;36(3):235-43.
Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine infusions for treatment refractory headache. Headache. 2017;57(2):276-82.
Etchison AR, Bos L, Ray M, McAllister K, Mohammed M, Park B. Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial. The West J Emerg Med. 2018;19(6):952-60.hyd
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.